Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/157225Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Bahare Salehi | |
| dc.creator | Natália Cruz-Martins | |
| dc.creator | Monica Butnariu | |
| dc.creator | Ioan Sarac | |
| dc.creator | Iulia-Cristina Bagiu | |
| dc.creator | Shahira M. Ezzat | |
| dc.creator | Jinfan Wang | |
| dc.creator | outros | |
| dc.date.accessioned | 2024-08-21T23:08:12Z | - |
| dc.date.available | 2024-08-21T23:08:12Z | - |
| dc.date.issued | 2022 | |
| dc.identifier.issn | 1040-8398 | |
| dc.identifier.other | sigarra:660283 | |
| dc.identifier.uri | https://hdl.handle.net/10216/157225 | - |
| dc.language.iso | eng | |
| dc.rights | restrictedAccess | |
| dc.title | Hesperetin's health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations | |
| dc.type | Artigo em Revista Científica Internacional | |
| dc.contributor.uporto | Faculdade de Medicina | |
| dc.identifier.doi | 10.1080/10408398.2021.1875979 | |
| Appears in Collections: | FMUP - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 660283.pdf Restricted Access | 2.13 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.